Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein.
about
Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulationCortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaineHIV, opiates, and enteric neuron dysfunctionHIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cellsHIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicityHuman immunodeficiency virus type 1 Tat protein decreases cyclic AMP synthesis in rat microglia culturesMultiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infectionEffects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergismNicotine attenuates the effect of HIV-1 proteins on the neural circuits of working and contextual memoriesNeonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation.Neonatal hippocampal Tat injections: developmental effects on prepulse inhibition (PPI) of the auditory startle response.Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measuresHuman immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.HIV-1 Tat-induced changes in synaptically-driven network activity adapt during prolonged exposure.Repeated cocaine treatment enhances HIV-1 Tat-induced cortical excitability via over-activation of L-type calcium channels.STAT3 and its phosphorylation are involved in HIV-1 Tat-induced transactivation of glial fibrillary acidic proteinHIV-1-Tat excites cardiac parasympathetic neurons of nucleus ambiguus and triggers prolonged bradycardia in conscious rats.Time-Dependent, HIV-Tat-Induced Perturbation of Human Neurons In Vitro: Towards a Model for the Molecular Pathology of HIV-Associated Neurocognitive DisordersHigh-performance capillary electrophoresis for determining HIV-1 Tat protein in neurons.Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysisMechanisms of HIV-tat-induced phosphorylation of N-methyl-D-aspartate receptor subunit 2A in human primary neurons: implications for neuroAIDS pathogenesisInteractions of human immunodeficiency virus-1 proteins with neurons: possible role in the development of human immunodeficiency virus-1-associated dementia.Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na⁺ influx, mitochondrial instability, and Ca²⁺ overload.Activation of Egr-1 expression in astrocytes by HIV-1 Tat: new insights into astrocyte-mediated Tat neurotoxicity.Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibilityHIV neurotoxicity: potential therapeutic interventionsTat-induced histopathological alterations mediate hippocampus-associated behavioural impairments in rats.Creatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury.Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder.HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs.Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.T-cell and neuronal apoptosis in HIV infection: implications for therapeutic intervention.Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity.Ketone bodies protection against HIV-1 Tat-induced neurotoxicity.Enduring cortical alterations after a single in-vivo treatment of HIV-1 Tat.HIV-1 Tat-Mediated Calcium Dysregulation and Neuronal Dysfunction in Vulnerable Brain Regions.Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disordersEffect of HIV clade differences on the onset and severity of HIV-associated neurocognitive disorders.Viruses and the immune system: their roles in seizure cascade development.Differential long-term neurotoxicity of HIV-1 proteins in the rat hippocampal formation: a design-based stereological study
P2860
Q22253485-9927722A-8506-4249-8AA3-681C188C2E55Q27013928-D9F1C4BC-1650-4479-8EE0-852DFD84B28AQ27023420-79697EAF-0F9F-4569-BB53-BB9F1A98A600Q28144137-4F3B145D-724E-44DA-8DFD-D6437EF48ACAQ28210557-08EC3E07-6029-4A93-9F4A-084F57BBD29BQ28212110-2F2D21EE-6900-4112-8A9E-416A722F1D96Q28246872-34136A73-5E9E-4AAB-8AD0-B50C4ACDFA55Q28660034-3E645B68-8385-4A10-9D95-998672B70A55Q30278962-4084BAA8-F5C2-4D4F-BDDC-DF39724E93A5Q30399828-89D7B3D3-58F0-4D8F-8181-4495ED5EE6F2Q30437301-5CF36B63-1180-43E0-8992-4A81B9176AA2Q30486458-63B6939B-457C-473C-B0F4-006B3D3B163AQ30497248-575D6B25-2892-4DAD-9ECD-8BC36FC57786Q30638542-09F4AE64-90E5-4BA8-B924-7622DE8F1C09Q33605370-AE30C815-BCC2-45DF-90DF-197B0F727368Q33675464-0607E902-B00C-4D2B-8754-A3A2ED3758B6Q33701989-FFCA0458-B974-42E1-81D5-C8221C0E4E37Q33734695-C63DBCC6-DA5E-410F-9F19-370328AC5EDAQ33797753-223FB326-83FD-4863-BF69-DB8EDBD31A91Q33797852-A2D2F448-0B6A-41B7-8FBA-DBD6C62C1A87Q33882476-E032E1B9-4124-407A-BDA3-34824644A87DQ34145508-4B3A2D2E-1E72-45E1-A434-40CCCA587218Q34197724-7B2F1806-990B-4F0D-9A32-99824BA0F8FDQ34666037-0B77736E-3F96-4E00-A606-09BFAE9ED9A5Q34755001-98A638EB-C96D-413B-A1DC-B73D4F32388DQ34795283-B7DF2B71-8364-49CC-8C48-79F31F8B5E68Q35097305-3132C301-3723-4BAD-93D0-D1D10F2FB4A8Q35215063-5F29A494-9808-410E-B870-D9F55B4AB4C6Q35366778-9478977B-124F-4876-898D-E1F583B1A3C0Q35562611-8C7F5175-A7A2-45AC-B11B-8D3E5C3FC1F4Q35606725-4E5CB843-B3B2-4C4C-A836-B831AADE3842Q35613792-00E2D565-8ED4-4EA3-92F4-3726D0F59978Q36148402-7A0EBAE5-2B24-43AA-B7C3-3D7038B44F76Q36166231-1194D94A-396B-40D1-BD06-83F21D2215A2Q36562431-02FC736D-EFA7-4FFD-8196-37DC728ED9C8Q36634476-1FA80422-E4AC-4C6C-9B66-195A6263BF8FQ36868552-11CC45DB-7B56-403D-8497-4FD09EEF0DEBQ36993831-A6D6B9F1-B5EA-471D-9F93-EC69011FD935Q37060468-E87568A2-8C50-47D4-AA20-08375C769636Q37092361-292FFC4F-4C69-4789-B30F-6CCB624ED5D7
P2860
Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein.
@en
Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein.
@nl
type
label
Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein.
@en
Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein.
@nl
prefLabel
Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein.
@en
Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein.
@nl
P2093
P1433
P1476
Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein
@en
P2093
P304
P356
10.1016/S0306-4522(97)00174-7
P407
P577
1998-01-01T00:00:00Z